ChartRow logo
Data provided bySource: Twelve Data
CCEP
$118.57+1.40%
as of close, Nov 13, 2026
☾ AH $118.57 +1.40%
PeersPEPMNSTKDPCOKEKOBUD
Share this page

CCEP financial statements

The full income statement, balance sheet, and cash-flow statement for Coca-Cola Europacific Partners plc (CCEP), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +14.4%10Y CAGR +12.9%
$23.7B FY25
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Gross profit

5Y CAGR +14.6%10Y CAGR +12.6%
$8.4B FY25
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Operating income

5Y CAGR +27.8%5Y CAGR +27.8%
$3.2B FY25
FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Net income

5Y CAGR +31.6%5Y CAGR +31.6%
$2.2B FY25
FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

EPS (diluted)

5Y CAGR +31.1%10Y CAGR +7.1%
$4.82 FY25
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Operating cash flow

5Y CAGR +14.5%10Y CAGR +12.6%
$3.3B FY25
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Capital expenditure

5Y CAGR +16.4%10Y CAGR +10.1%
$848.6M FY25
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Free cash flow

5Y CAGR +13.9%10Y CAGR +13.6%
$2.5B FY25
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Shares (diluted)

5Y +0.0%10Y +94.0%
456M FY25
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Dividend per share

5Y CAGR +19.2%10Y CAGR +7.9%YoY +29.3%
$2.34 FY25— Q4 '25
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Q1 '16Q2 '16Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q4 '19Q4 '20Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Every CCEP chart on Trends →

Shares outstanding (point-in-time)

2017-12 484.6M2018-12 474.9M2019-12 456.4M2020-12 454.6M2021-12 456.2M2022-12 457.1M2023-12 459.2M2024-12 460.9M2025-12 449.1M-7.3% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue23.7B+7.0%22.1B+11.7%19.8B+8.6%18.2B+11.9%16.3B+34.6%
8.42B+7.9%7.80B+7.3%7.27B+11.0%6.55B+8.8%6.02B+41.3%
Cost of revenue15.2B+6.5%14.3B+14.2%12.5B+7.3%11.7B+13.7%10.3B+31.0%
Operating income3.16B+37.0%2.31B-8.8%2.53B+15.3%2.19B+22.4%1.79B+93.4%
Interest expense346M+17.7%294M+47.1%200M+5.1%190M-6.4%203M+23.9%
Pre-tax income2.91B+38.8%2.09B-12.1%2.38B+15.7%2.06B+26.0%1.63B+106.3%
Income tax668M+25.4%532M-7.8%577M+25.9%459M-1.6%466M+107.5%
2.24B+43.4%1.56B-13.5%1.80B+12.8%1.60B+36.9%1.17B+105.8%
Net income to common2.20B+43.3%1.53B-15.0%1.80B+13.8%1.59B+36.6%1.16B+104.6%
$4.82+44.7%$3.33-15.1%$3.93+13.4%$3.46+36.1%$2.54+104.6%
EPS (basic)$4.82+44.7%$3.33-15.4%$3.94+13.4%$3.47+36.5%$2.54+104.6%
Weighted-avg shares (basic)456M-0.9%460M+0.2%459M+0.4%457M+0.2%456M+0.2%
Weighted-avg shares (diluted)456M-1.1%461M+0.4%459M+0.2%458M+0.2%457M+0.2%
Dividends per share$2.34+9.4%$2.14+7.8%$1.98+12.8%$1.76+6.1%$1.66+70.9%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
7.15B+3.6%6.90B-5.4%7.29B+4.2%7.00B+7.3%6.52B+30.1%
Cash & equivalents1.08B-33.6%1.62B+3.7%1.57B+5.6%1.48B-6.9%1.59B-14.9%
Inventory1.82B+8.8%1.67B+11.6%1.50B+1.4%1.48B+12.7%1.31B+56.4%
35.1B+8.6%32.3B+0.1%32.3B+3.0%31.4B-4.8%32.9B+39.2%
Property, plant & equipment———5.56B-6.4%5.94B+25.2%
Goodwill5.33B+9.5%4.87B-2.2%4.98B+1.2%4.92B-6.0%5.24B+69.1%
Total non-current assets28.0B+10.0%25.4B+1.7%25.0B+2.6%24.4B-7.8%26.4B+41.7%
Total current liabilities8.92B+5.3%8.47B+5.4%8.03B+2.7%7.82B+13.4%6.90B+35.5%
25.4B+10.3%23.0B-2.2%23.5B+0.4%23.4B-5.6%24.8B+52.5%
Long-term debt12.0B+16.3%10.3B-7.3%11.1B-1.5%11.3B-15.3%13.4B+70.1%
9.21B+4.4%8.82B+0.2%8.81B+10.5%7.97B+0.0%7.96B+7.5%
Total equity incl. non-controlling9.76B+4.5%9.34B+6.1%8.81B+10.5%7.97B-2.4%8.17B+10.2%
Common shares issued449M-2.6%461M+0.4%459M+0.5%457M+0.2%456M+0.3%
Shares outstanding (cover)449M-2.6%461M+0.4%459M+0.5%457M+0.2%456M+0.3%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
3.34B+0.9%3.31B+9.1%3.03B-1.6%3.08B+23.2%2.50B+47.4%
Intangible amortization
————105M+48.9%
Capital expenditure849M-0.8%856M+17.7%727M+38.2%526M+27.4%413M+4.0%
Free cash flow2.49B+1.5%2.46B+6.4%2.31B-9.8%2.56B+22.4%2.09B+60.6%
Acquisitions0.000.000.000.000.00
Long-term debt issued1.50B+37.7%1.09B+45.3%750M0.00-100.0%5.77B+216.6%
Long-term debt repaid2.06B+58.1%1.31B+4.2%1.25B+27.0%987M-12.2%1.12B+73.2%
Common stock issued1.13M-96.6%33.5M-26.2%45.4M+208.4%14.7M-55.5%33.1M+107.5%
Common stock repurchased1.14B+14933.8%7.57M0.000.000.00
Dividends paid1.05B+6.6%984M+8.2%909M+13.3%803M+6.4%755M+71.5%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap40.7B+15.0%35.4B+16.1%30.5B+20.9%25.2B-1.1%25.5B+12.6%
P/E18.2×-19.8%22.7×+18.9%19.1×-11.7%21.6×-1.1%21.8×-45.3%
P/S1.7×+7.5%1.6×-4.3%1.7×+8.0%1.6×-1.1%1.6×-16.3%
P/B4.4×+10.2%4.0×+4.8%3.8×+20.8%3.2×-1.1%3.2×+4.8%
P/FCF16.3×+13.3%14.4×+20.9%11.9×-1.2%12.1×-1.1%12.2×-29.9%
Earnings yield5.5%+24.6%4.4%-15.9%5.2%+13.3%4.6%+1.1%4.6%+82.7%
FCF yield6.1%-11.8%6.9%-17.3%8.4%+1.2%8.3%+1.1%8.2%+42.6%
Dividend yield2.6%-7.4%2.8%-6.3%3.0%-6.5%3.2%+7.2%3.0%+52.2%
Source filing20-F20-F20-F20-F20-F

About this data

Source: CCEP’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CCEP filings on SEC EDGAR → Not investment advice.